Cytosolix is a platform that produces novel derivatives of known small-molecule oncology drugs. These derivatives selectively target cancer cells by targeting acidity in the tumor microenvironment, significantly improving the efficacy of treatment by reducing dose-limiting toxicities.
Location: United States, Connecticut, Tolland
Employees: 1-10
Total raised: $230K
Investors 3
| Date | Name | Website |
| - | Connecticu... | ctinnovati... |
| 08.07.2022 | Creative D... | creativede... |
| - | FirstXFoun... | firstxfoun... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.06.2019 | - | $230K | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| - | Cytosolix | “Cytosolix Homepage” | fastfounde... |